They are safe and effective when taken under medical supervision
This decision arises as scrutiny over the safety of GLP-1 drugs, a class that includes Ozempic, intensifies amid the growing popularity and competition in the obesity treatment market
The choice depends on the compounds intended use, absorption goals, and provider direction
Our findings demonstrate significant reductions in mortality, MAKE, and MALO across diverse patient populations, suggesting that this therapeutic approach could represent a paradigm shift in MASLD management
Several months into its release, the coupon program was dramatically altered to make the medication coupon available only to those who had a diagnosis of Type II diabetes
Conversely, the NICE (2015) guidance gave a more limited choice after metformin and put the GLP-1 analogue class as a clear fourth-line option